$NLNK LUMOS PHARMA, INC. Insider Trading
Get free email notifications about insider trading in LUMOS PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LUMOS PHARMA, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in LUMOS PHARMA, INC. for free.
CIK Number: 0001126234
IRS Number: 421491350
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: NLNK
Company Address: 4200 MARATHON BLVD. SUITE 200 AUSTIN 78756
Phone number: 515-296-5555
Former name: NEWLINK GENETICS CORP, date of change: 2000-10-12
Market Capitalization: $408.17M
Prev close: $13.67
Average Daily Volume: 258,305
Days Low: $13.17
Year Low: $9.23
Year High: $26.49
LUMOS PHARMA, INC. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 03 2021 | NLNK | LUMOS PHARMA, INC. | Schuchart Aaron | Chief Business Offi ... | Option Exercise | A | 10.13 | 7,805 | 79,065 | 7,805 | |
Jun 03 2021 | NLNK | LUMOS PHARMA, INC. | Schuchart Aaron | Chief Business Offi ... | Option Exercise | A | 10.13 | 7,805 | 79,065 | 7,805 | |
May 24 2021 | NLNK | LUMOS PHARMA, INC. | LALANDE KEVIN M. | Director | Option Exercise | A | 10.36 | 2,910 | 30,148 | 2,910 | |
May 24 2021 | NLNK | LUMOS PHARMA, INC. | LALANDE KEVIN M. | Director | Grant | A | 0.00 | 367 | 0 | 1,076 | 709 to 1.1 K (+51.76 %) |
Apr 05 2021 | NLNK | LUMOS PHARMA, INC. | POWERS BRADLEY J | General Counsel | Payment of Exercise | F | 12.25 | 342 | 4,190 | 5,082 | 5.4 K to 5.1 K (-6.31 %) |
Apr 05 2021 | NLNK | LUMOS PHARMA, INC. | McKew John C. | Chief Scientific Of ... | Payment of Exercise | F | 12.25 | 1,036 | 12,691 | 13,226 | 14.3 K to 13.2 K (-7.26 %) |
Apr 05 2021 | NLNK | LUMOS PHARMA, INC. | Lawley Lori D | Principal Accountin ... | Payment of Exercise | F | 12.25 | 274 | 3,357 | 5,437 | 5.7 K to 5.4 K (-4.80 %) |
Apr 05 2021 | NLNK | LUMOS PHARMA, INC. | Langren Carl W. | Chief Financial Off ... | Payment of Exercise | F | 12.25 | 683 | 8,367 | 11,494 | 12.2 K to 11.5 K (-5.61 %) |
Apr 05 2021 | NLNK | LUMOS PHARMA, INC. | Hawkins Richard J | Chief Executive Off ... | Payment of Exercise | F | 12.25 | 1,522 | 18,645 | 745,382 | 746.9 K to 745.4 K (-0.20 %) |
Jan 08 2021 | NLNK | LUMOS PHARMA, INC. | Flynn James E | 10% Owner | Sell | S | 22.24 | 101,600 | 2,259,797 | 784,568 | 886.2 K to 784.6 K (-11.47 %) |
Jan 08 2021 | NLNK | LUMOS PHARMA, INC. | Flynn James E | 10% Owner | Sell | S | 23.57 | 3,912 | 92,194 | 886,168 | 890.1 K to 886.2 K (-0.44 %) |
Jan 08 2021 | NLNK | LUMOS PHARMA, INC. | Flynn James E | 10% Owner | Sell | S | 24.11 | 1,000 | 24,108 | 890,080 | 891.1 K to 890.1 K (-0.11 %) |
Jan 08 2021 | NLNK | LUMOS PHARMA, INC. | Flynn James E | 10% Owner | Sell | S | 25.05 | 4,378 | 109,665 | 891,080 | 895.5 K to 891.1 K (-0.49 %) |
Jan 08 2021 | NLNK | LUMOS PHARMA, INC. | Flynn James E | 10% Owner | Sell | S | 24.35 | 11,794 | 287,157 | 895,458 | 907.3 K to 895.5 K (-1.30 %) |
Jan 08 2021 | NLNK | LUMOS PHARMA, INC. | Flynn James E | 10% Owner | Sell | S | 22.64 | 931 | 21,082 | 907,252 | 908.2 K to 907.3 K (-0.10 %) |